Sector: Pharmaceutical Preparations Region: France

: | New York Stock Exchange: SNY

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in healthcare, with 6 growth platforms: emerging markets, vaccines, consumer healthcare, diabetes treatments, innovative products and animal health. Through the acquisition of Genzyme, Sanofi has strongly reinforced its footprint in rare diseases.

Investor Calendar

Feb 7, 2013 | 2012 Earnings Call

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

Sanofi: Second Quarter Results 2013

Interview with Christopher A. Viehbacher, Chief Executive Officer of Sanofi

Sanofi video

Sanofi: Second Quarter Results 2013

Sanofi video

Sanofi Corporate video

Sanofi video

We Are Sanofi


Christopher A. Viehbacher, Chief Executive Officer
Christopher A. Viehbacher, holds German and Canadian nationalities. He is a graduate of the Queens University (Ontario - Canada) and a certified public accountant. Since December 2008, he has held the position of Chief Executive Officer, Sanofi and is a Board member, in addition to being a member of the Strategy Committee. He is also Chairman of Genzyme, which Sanofi acquired in February 2011.
Jerome Contamine, Executive Vice President, Chief Financial Officer
Jérôme Contamine is a Graduate of Ecole Polytechnique (X), France’s most prestigious engineering school, and ENSAE, the national statistics and economics engineering school. He graduated from the elite ENA - Ecole Nationale d’Administration - opting for the French Court of Audit - “Cour des Comptes” in 1984.

News & Analysis